Sherbrooke Park Advisers LLC Harmony Biosciences Holdings, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $230 Billion
- Q2 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 12,719 shares of HRMY stock, worth $363,381. This represents 0.17% of its overall portfolio holdings.
Number of Shares
12,719Holding current value
$363,381% of portfolio
0.17%Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
291Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$189 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$167 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$146 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$46.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$45.2 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.69B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...